TNF and psoriasis: Psoriasis is a chronic, immune-mediated, inflammatory disease characterized by dysregulation of the tumor necrosis factor (TNF)-α/interleukin (IL)-23/IL-17 axis, affecting approximately 2–4% of the global population [1].